Why Your Favorite ‘Coronavirus Stock’ Just Took Wall Street on a Nasty Ride


Why Your Favorite ‘Coronavirus Stock’ Just Took Wall Street on a Nasty Ride
Gilead was quick to downplay a leaked WHO document showing its coronavirus treatment failed in a Chinese trial. But the numbers don’t add up.
The post Why Your Favorite ‘Coronavirus Stock’ Just Took Wall Street on a Nasty Ride appeared first on CCN.com
Go to Source